© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
New Orleans--A combination of common clinical factors can accurately predict which patients who have biochemical failure after radical prostatectomy are likely to develop metastatic progression, said investigators from Memorial Sloan-Kettering Cancer Center, New York.
Related Content:
News